Brief: Pharmena Plans To Start Preclinical Study Of 1-MNA Drug
Feb 22 (Reuters) - Pharmena SA PHR.WA :
* SAYS PLANS TO START VIA ITS UNIT IN US PRECLINICAL STUDY
OF
1-MNA DRUG FOR FUTURE CLINICAL TRIAL OF IIB PHASE
Source text for Eikon: ID:nEM4mB6m0a
Further company coverage: PHR.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Recent news on Pharmena SA
See all newsBrief: Pharmena Makes Cession Of Rights And Obligations From Unit Menavitin
Brief: Pharmena Signs Two Distribution Deals For US, Canada And Mexico Markets
Brief: Pharmena 9-Month Net Loss Narrows To 0.7 Mln Zlotys
Brief: Pharmena Plans To Separate Dermocosmetic Business
Brief: Pharmena H1 Net Loss Narrows To 0.6 Mln Zlotys